Optimize IAS
  • Home
  • About Us
  • Courses
    • Prelims Test Series
      • LAQSHYA 2026 Prelims Mentorship
    • Mains Mentorship
      • Arjuna 2026 Mains Mentorship
    • Mains Master Notes
  • Portal Login
    • Home
    • About Us
    • Courses
      • Prelims Test Series
        • LAQSHYA 2026 Prelims Mentorship
      • Mains Mentorship
        • Arjuna 2026 Mains Mentorship
      • Mains Master Notes
    • Portal Login
    U.S. firm Eli Lilly unveils drug for obesity, diabetes
    March 21, 2025

        U.S. firm Eli Lilly unveils drug for obesity, diabetes Sub: Sci Sec: Health Context: American pharmaceutical giant Eli Lilly and Company introduced Mounjaro (tirzepatide) in India after receiving marketing authorization from the Central Drugs Standard Control Organisation (CDSCO). India has around 101 million people with diabetes. The growing demand for GLP-1 class drugs […]

    Posted in: DPN Topics ,
    Tags: Science and tech , U.S. firm Eli Lilly unveils drug for obesity ,

    Recent Posts

    • Daily Prelims Notes 23 March 2025 March 23, 2025
    • Challenges in Uploading Voting Data March 23, 2025
    • Fertilizers Committee Warns Against Under-Funding of Nutrient Subsidy Schemes March 23, 2025
    • Tavasya: The Fourth Krivak-Class Stealth Frigate Launched March 23, 2025
    • Indo-French Naval Exercise Varuna 2024 March 23, 2025
    • No Mismatch Between Circulating Influenza Strains and Vaccine Strains March 23, 2025
    • South Cascade Glacier March 22, 2025
    • Made-in-India Web Browser March 22, 2025
    • Charting a route for IORA under India’s chairship March 22, 2025
    • Mar-a-Lago Accord and dollar devaluation March 22, 2025
    Footer logo
    Copyright © 2015 MasterStudy Theme by Stylemix Themes
        Search